These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24239777)

  • 1. N-glycosylation mutations within hepatitis B virus surface major hydrophilic region contribute mostly to immune escape.
    Yu DM; Li XH; Mom V; Lu ZH; Liao XW; Han Y; Pichoud C; Gong QM; Zhang DH; Zhang Y; Deny P; Zoulim F; Zhang XX
    J Hepatol; 2014 Mar; 60(3):515-22. PubMed ID: 24239777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional analysis of hepatitis B virus immune escape mutants with insertion mutations in the surface antigen].
    Yu SL; Yu DM; Zhang DH; Jiang JH; Chen J; Deng L; Zhang XX
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):510-3. PubMed ID: 24074709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression.
    Salpini R; Colagrossi L; Bellocchi MC; Surdo M; Becker C; Alteri C; Aragri M; Ricciardi A; Armenia D; Pollicita M; Di Santo F; Carioti L; Louzoun Y; Mastroianni CM; Lichtner M; Paoloni M; Esposito M; D'Amore C; Marrone A; Marignani M; Sarrecchia C; Sarmati L; Andreoni M; Angelico M; Verheyen J; Perno CF; Svicher V
    Hepatology; 2015 Mar; 61(3):823-33. PubMed ID: 25418031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors.
    Huang CH; Yuan Q; Chen PJ; Zhang YL; Chen CR; Zheng QB; Yeh SH; Yu H; Xue Y; Chen YX; Liu PG; Ge SX; Zhang J; Xia NS
    J Hepatol; 2012 Oct; 57(4):720-9. PubMed ID: 22634131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBsAg sT123N mutation induces stronger antibody responses to HBsAg and HBcAg and accelerates in vivo HBsAg clearance.
    Li S; Zhao K; Liu S; Wu C; Yao Y; Cao L; Hu X; Zhou Y; Wang Y; Pei R; Lu M; Chen X
    Virus Res; 2015 Dec; 210():119-25. PubMed ID: 26260331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional N-glycosylation mutation in the major hydrophilic region of hepatitis B virus S gene is a risk indicator for hepatocellular carcinoma occurrence in patients with coexistence of HBsAg/anti-HBs.
    Qiao Y; Lu S; Xu Z; Li X; Zhang K; Liu Y; Zhao L; Chen R; Si L; Lin S; Xu D; Li J
    Oncotarget; 2017 Sep; 8(37):61719-61730. PubMed ID: 28977899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation in the S gene of hepatitis B virus and anti-HBs subtype-nonspecificity contributed to the co-existence of HBsAg and anti-HBs in patients with chronic hepatitis B virus infection.
    Fu X; Chen J; Chen H; Lin J; Xun Z; Li S; Liu C; Zeng Y; Chen T; Yang B; Ou Q
    J Med Virol; 2017 Aug; 89(8):1419-1426. PubMed ID: 28198078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.
    Chen Y; Qian F; Yuan Q; Li X; Wu W; Guo X; Li L
    J Clin Virol; 2011 Nov; 52(3):198-203. PubMed ID: 21840251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and expression of hepatitis B surface antigen escape variants within the "a" determinant by site directed mutagenesis.
    Golsaz Shirazi F; Amiri MM; Mohammadi H; Bayat AA; Roohi A; Khoshnoodi J; Zarnani AH; Jeddi-Tehrani M; Kardar GA; Shokri F
    Iran J Immunol; 2013 Sep; 10(3):127-38. PubMed ID: 24076590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication.
    Wu C; Zhang X; Tian Y; Song J; Yang D; Roggendorf M; Lu M; Chen X
    J Gen Virol; 2010 Feb; 91(Pt 2):483-92. PubMed ID: 19812261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
    Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene.
    Koyanagi T; Nakamuta M; Sakai H; Sugimoto R; Enjoji M; Koto K; Iwamoto H; Kumazawa T; Mukaide M; Nawata H
    Med Sci Monit; 2000; 6(6):1165-9. PubMed ID: 11208474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced antigenicity of naturally occurring hepatitis B surface antigen variants with substitutions at the amino acid residue 126.
    Qiu S; Zhang J; Tian Y; Yang Y; Huang H; Yang D; Lu M; Xu Y
    Intervirology; 2008; 51(6):400-6. PubMed ID: 19258718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PreS deletion mutations of hepatitis B virus in chronically infected patients with simultaneous seropositivity for hepatitis-B surface antigen and anti-HBS antibodies.
    Huang X; Qin Y; Zhang P; Tang G; Shi Q; Xu J; Qi F; Shen Q
    J Med Virol; 2010 Jan; 82(1):23-31. PubMed ID: 19950231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of hepatitis B surface antigen and anti-HBs in Chinese chronic hepatitis B virus patients relating to genotype C and mutations in the S and P gene reverse transcriptase region.
    Liu W; Hu T; Wang X; Chen Y; Huang M; Yuan C; Guan M
    Arch Virol; 2012 Apr; 157(4):627-34. PubMed ID: 22222283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers.
    Colson P; Borentain P; Motte A; Henry M; Moal V; Botta-Fridlund D; Tamalet C; Gérolami R
    Virology; 2007 Oct; 367(1):30-40. PubMed ID: 17573090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.